BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 27255165)

  • 1. Significance of myelodysplastic syndrome-associated somatic variants in the evaluation of patients with pancytopenia and idiopathic cytopenias of undetermined significance.
    Fernandez-Pol S; Ma L; Ohgami RS; Arber DA
    Mod Pathol; 2016 Sep; 29(9):996-1003. PubMed ID: 27255165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of somatic mutation in unexplained blood cytopenia.
    Malcovati L; Gallì A; Travaglino E; Ambaglio I; Rizzo E; Molteni E; Elena C; Ferretti VV; Catricalà S; Bono E; Todisco G; Bianchessi A; Rumi E; Zibellini S; Pietra D; Boveri E; Camaschella C; Toniolo D; Papaemmanuil E; Ogawa S; Cazzola M
    Blood; 2017 Jun; 129(25):3371-3378. PubMed ID: 28424163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in idiopathic cytopenia of undetermined significance assist diagnostics and correlate to dysplastic changes.
    Hansen JW; Westman MK; Sjö LD; Saft L; Kristensen LS; Ørskov AD; Treppendahl M; Andersen MK; Grønbaek K
    Am J Hematol; 2016 Dec; 91(12):1234-1238. PubMed ID: 27717004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic cytopenia of undetermined significance and the minimal criteria for a diagnosis of myelodysplastic syndrome.
    Pavlu J; Emmerson J; Marks AJ; Bain BJ
    Leuk Lymphoma; 2011 Mar; 52(3):515-6. PubMed ID: 21323527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and Clinical Studies of Patients With Increased Multinucleated Megakaryocytes in Bone Marrow as an Isolated Finding: A Diagnostic Pitfall for Myelodysplastic Syndrome.
    Zheng G; He R; Reichard KK; Peterson JF; Olteanu H; Oliveira JL; Rangan A; Chen D; Shi M
    Am J Surg Pathol; 2021 Nov; 45(11):1534-1540. PubMed ID: 33999554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study.
    Myers KC; Furutani E; Weller E; Siegele B; Galvin A; Arsenault V; Alter BP; Boulad F; Bueso-Ramos C; Burroughs L; Castillo P; Connelly J; Davies SM; DiNardo CD; Hanif I; Ho RH; Karras N; Manalang M; McReynolds LJ; Nakano TA; Nalepa G; Norkin M; Oberley MJ; Orgel E; Pastore YD; Rosenthal J; Walkovich K; Larson J; Malsch M; Elghetany MT; Fleming MD; Shimamura A
    Lancet Haematol; 2020 Mar; 7(3):e238-e246. PubMed ID: 31879230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of somatic panels for the detection of haematopoietic transformation in children and young adults with leukaemia predisposition syndromes and with acquired cytopenias.
    Noy-Lotan S; Krasnov T; Dgany O; Jeison M; Yanir AD; Gilad O; Toledano H; Barzilai-Birenboim S; Yacobovich J; Izraeli S; Tamary H; Steinberg-Shemer O
    Br J Haematol; 2021 May; 193(3):570-580. PubMed ID: 33368157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASXL1 is a molecular predictor in idiopathic cytopenia of undetermined significance.
    Shin DY; Park JK; Kim SM; Im K; Kim JA; Kim SY; Hwang SM; Yoon SS; Lee DS
    Leuk Lymphoma; 2019 Mar; 60(3):756-763. PubMed ID: 30301403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The cause of cytopenia of undetermined significance can often be found by using next generation sequencing].
    Hansen JW; Husby S; Grønbæk K
    Ugeskr Laeger; 2017 Jun; 179(25):. PubMed ID: 28648154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FLT3 and NPM1 mutations in myelodysplastic syndromes: Frequency and potential value for predicting progression to acute myeloid leukemia.
    Bains A; Luthra R; Medeiros LJ; Zuo Z
    Am J Clin Pathol; 2011 Jan; 135(1):62-9. PubMed ID: 21173125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.
    Rogers HJ; Vardiman JW; Anastasi J; Raca G; Savage NM; Cherry AM; Arber D; Moore E; Morrissette JJ; Bagg A; Liu YC; Mathew S; Orazi A; Lin P; Wang SA; Bueso-Ramos CE; Foucar K; Hasserjian RP; Tiu RV; Karafa M; Hsi ED
    Haematologica; 2014 May; 99(5):821-9. PubMed ID: 24463215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of genetic and clinical aspects in patients with acute myeloid leukemia and myelodysplastic syndromes all with more than 50% of bone marrow erythropoietic cells.
    Bacher U; Haferlach C; Alpermann T; Kern W; Schnittger S; Haferlach T
    Haematologica; 2011 Sep; 96(9):1284-92. PubMed ID: 21606170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential occurrence of spliceosome mutations in acute myeloid leukemia with preceding myelodysplastic syndrome and/or myelodysplasia morphology.
    Cho YU; Jang S; Seo EJ; Park CJ; Chi HS; Kim DY; Lee JH; Lee JH; Lee KH; Koh KN; Im HJ; Seo JJ; Park SH; Park YM; Lee JK
    Leuk Lymphoma; 2015; 56(8):2301-8. PubMed ID: 25487075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.
    Davidsson J; Puschmann A; Tedgård U; Bryder D; Nilsson L; Cammenga J
    Leukemia; 2018 May; 32(5):1106-1115. PubMed ID: 29535429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Next-Generation Sequencing in Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia Aids Diagnosis in Challenging Cases and Identifies Frequent Spliceosome Mutations in Transformed Acute Myeloid Leukemia.
    Reinig E; Yang F; Traer E; Arora R; Brown S; Rattray R; Braziel R; Fan G; Press R; Dunlap J
    Am J Clin Pathol; 2016 Apr; 145(4):497-506. PubMed ID: 27124934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients.
    Keel SB; Scott A; Sanchez-Bonilla M; Ho PA; Gulsuner S; Pritchard CC; Abkowitz JL; King MC; Walsh T; Shimamura A
    Haematologica; 2016 Nov; 101(11):1343-1350. PubMed ID: 27418648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of hematological malignancies and peripheral cytopenias.
    Jha A
    J Nepal Health Res Counc; 2013 Sep; 11(25):273-8. PubMed ID: 24908530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique ethnic features of
    Choi EJ; Cho YU; Hur EH; Jang S; Kim N; Park HS; Lee JH; Lee KH; Kim SH; Hwang SH; Seo EJ; Park CJ; Lee JH
    Haematologica; 2022 Feb; 107(2):510-518. PubMed ID: 33626862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. U2AF1 mutations in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome.
    Qian J; Yao DM; Lin J; Qian W; Wang CZ; Chai HY; Yang J; Li Y; Deng ZQ; Ma JC; Chen XX
    PLoS One; 2012; 7(9):e45760. PubMed ID: 23029227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of TP53 mutations in clonal cytopenia of undetermined significance.
    Wang W; Routbort MJ; Ok CY; Patel KP; Sun Y; Kanagal-Shamanna R; Medeiros LJ; Wang SA
    Am J Hematol; 2017 Aug; 92(8):E175-E177. PubMed ID: 28494520
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.